These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
701 related articles for article (PubMed ID: 24463215)
1. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215 [TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia. Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602 [TBL] [Abstract][Full Text] [Related]
3. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667 [TBL] [Abstract][Full Text] [Related]
4. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia. Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821 [TBL] [Abstract][Full Text] [Related]
5. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833 [TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality]. Calderón-Cabrera C; Falantes JF; Bernal R; Pérez-Simón JA Med Clin (Barc); 2015 Sep; 145(5):224-6. PubMed ID: 25190583 [No Abstract] [Full Text] [Related]
7. Unusual findings of acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): A multicenter study. Gong X; Yu T; Tang Q; Fu Y; Wu J; Zhu Y; Tu H; Ge H; Lu X; Gong D; Zhao X Int J Lab Hematol; 2019 Jun; 41(3):380-386. PubMed ID: 30793839 [TBL] [Abstract][Full Text] [Related]
8. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2). Wang HY; Rashidi HH Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325 [TBL] [Abstract][Full Text] [Related]
9. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804 [TBL] [Abstract][Full Text] [Related]
10. De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification. Sun J; Konoplev SN; Wang X; Cui W; Chen SS; Medeiros LJ; Lin P Mod Pathol; 2011 Mar; 24(3):384-9. PubMed ID: 21113141 [TBL] [Abstract][Full Text] [Related]
11. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Jotterand Bellomo M; Parlier V; Mühlematter D; Grob JP; Beris P Cancer Genet Cytogenet; 1992 Apr; 59(2):138-60. PubMed ID: 1581880 [TBL] [Abstract][Full Text] [Related]
12. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation. Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N; Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702 [TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols. Sitges M; Boluda B; Garrido A; Morgades M; Granada I; Barragan E; Arnan M; Serrano J; Tormo M; Miguel Bergua J; Colorado M; Salamero O; Esteve J; Benavente C; Pérez-Encinas M; Coll R; Martí-Tutusaus JM; Brunet S; Sierra J; Ángel Sanz M; Montesinos P; Ribera JM; Vives S; Eur J Haematol; 2020 Aug; 105(2):138-147. PubMed ID: 32243655 [TBL] [Abstract][Full Text] [Related]
14. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26). Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775 [TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870 [TBL] [Abstract][Full Text] [Related]
17. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis. Lee EJ; Schiffer CA; Tomiyasu T; Testa JR Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480 [TBL] [Abstract][Full Text] [Related]
18. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26). Reiter E; Greinix H; Rabitsch W; Keil F; Schwarzinger I; Jaeger U; Lechner K; Worel N; Streubel B; Fonatsch C; Mitterbauer G; Kalhs P Ann Hematol; 2000 Jul; 79(7):374-7. PubMed ID: 10965785 [TBL] [Abstract][Full Text] [Related]
19. Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML. Weisser M; Haferlach C; Haferlach T; Schnittger S Leuk Lymphoma; 2007 Nov; 48(11):2145-51. PubMed ID: 17926191 [TBL] [Abstract][Full Text] [Related]
20. [Characteristics of cases with chromosome 3q21q26 aberrations]. Zhang Y; He Q; Shi Y; Dang H; Qiu JY; Huang XJ; Lu DP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):22-5. PubMed ID: 18315893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]